📋 Tender Overview
Contract awarded for Various medications { "detected_language": "romanian", "translated_text": "lot-0003, title: acetylcysteinum fluimucil (acetylcysteine) 100mg/ml 3ml, description: the estimated value of the largest subsequent contract anticipated to be awarded during the framework agreement: 1,804.50 lei excluding vat. estimates of the minimum and maximum quantities that could be requested during the entire framework agreement: minimum quantities 1 piece, maximum quantities 1600 vials. estimated calendar (frequency and value of contracts to be awarded): subsequent contracts will be concluded in a cascading manner depending on needs and the financial provisions allocated for this purpose: monthly/semi-annually/quarterly. in the event that the economic operator signing this framework agreement ranked first does not have the capacity to fully respond to the request (inability to ensure the entire requested quantity, non-compliance with the assumed conditions regarding quality, delivery time, price, validity, etc.), the contracting authority will send requests to the occupant of the second place, and in case of denial/lack of response from this party, to the occupant of the third place (when the framework agreement is signed with 3 economic operators), with the operator(s) ranked first, second, and/or third bearing the consequences for non-fulfillment of the obligations assumed, according to the provisions of art.111 para. (2) and (3) of h.g. 395/2016, with subsequent amendments and completions. lot-0014, title: ampicillinum 250 mg fl, description: the estimated value of the largest subsequent contract anticipated to be awarded during the framework agreement: 2,379.00 lei excluding vat. estimates of the minimum and maximum quantities that could be requested during the entire framework agreement: minimum quantities 1 vial, maximum quantities 4600 vials. estimated calendar (frequency and value of contracts to be awarded): subsequent contracts will be concluded in a cascading manner depending on needs and the financial provisions allocated for this purpose: monthly/semi-annually/quarterly. in the event that the economic operator signing this framework agreement ranked first does not have the capacity to fully respond to the request (inability to ensure the entire requested quantity, non-compliance with the assumed conditions regarding quality, delivery time, price, validity, etc.), the contracting authority will send requests to the occupant of the second place, and in case of denial/lack of response from this party, to the occupant of the third place (when the framework agreement is signed with 3 economic operators), with the operator(s) ranked first, second, and/or third bearing the consequences for non-fulfillment of the obligations assumed, according to the provisions of art.111 para. (2) and (3) of h.g. 395/2016, with subsequent amendments and completions. lot-0019, title: bromhexinum 8mg tablets, description: the estimated value of the largest subsequent contract anticipated to be awarded during the framework agreement: 60.00 lei excluding vat. estimates of the minimum and maximum quantities that could be requested during the entire framework agreement: minimum quantities 1 tablet, maximum quantities 350 tablets. estimated calendar (frequency and value of contracts to be awarded): subsequent contracts will be concluded in a cascading manner depending on needs and the financial provisions allocated for this purpose: monthly/semi-annually/quarterly. in the event that the economic operator signing this framework agreement ranked first does not have the capacity to fully respond to the request (inability to ensure the entire requested quantity, non-compliance with the assumed conditions regarding quality, delivery time, price, validity, etc.), the contracting authority will send requests to the occupant of the second place, and in case of denial/lack of response from this party, to the occupant of the third place (when the framework agreement is signed with 3 economic operators), with the operator(s) ranked first, second, and/or third bearing the consequences for non-fulfillment of the obligations assumed, according to the provisions of art.111 para. (2) and (3) of h.g. 395/2016, with subsequent amendments and completions. lot-0020, title: benzathini benzylpenicillinum 1200000 u.i. vial, description: the estimated value of the largest subsequent contract anticipated to be awarded during the framework agreement: 359.50 lei excluding vat. estimates of the minimum and maximum quantities that could be requested during the entire framework agreement: minimum quantities 1 vial, maximum quantities 40 vials. estimated calendar (frequency and value of contracts to be awarded): subsequent contracts will be concluded in a cascading manner depending on needs and the financial provisions allocated for this purpose: monthly/semi-annually/quarterly. in the event that the economic operator signing this framework agreement ranked first does not have the capacity to fully respond to the request (inability to ensure the entire requested quantity, non-compliance with the assumed conditions regarding quality, delivery time, price, validity, etc.), the contracting authority will send requests to the occupant of the second place, and in case of denial/lack of response from this party, to the occupant of the third place (when the framework agreement is signed with 3 economic operators), with the operator(s) ranked first, second, and/or third bearing the consequences for non-fulfillment of the obligations assumed, according to the provisions of art.111 para. (2) and (3) of h.g. 395/2016, with subsequent amendments and completions. lot-0021, title: benzylpenicillinum g (potassium) 1000000 ui vial, description: the estimated value of the largest subsequent contract estimated value excluding vat: 548.10 ron.Various medications